Literature DB >> 15727227

Multiple sclerosis in children under 10 years of age.

M Ruggieri1, P Iannetti, A Polizzi, L Pavone, L M E Grimaldi.   

Abstract

Despite the consistent amount of information accumulated in recent years on multiple sclerosis (MS) in childhood, many clinicians still view this condition as an exclusively young adult-onset disease and do not consider that it may occur and manifest even during infancy and pre-school age, suggesting that the number of MS cases in the paediatric age group may have been underestimated. Thus, the need to have practical parameters for therapeutic, counselling and educational purposes in such settings as caring for patients whose onset of disease is at very early ages may increasingly arise for practising clinicians. In addition, the clinical and radiographic criteria for the diagnosis of MS have not been validated in a paediatric MS population; accordingly, inclusion age at onset (such as for research purposes) is generally over 10 years. To highlight the peculiarities that characterise MS when it begins at this young age we have reviewed the literature and summarised our preliminary results with the national registry of the Italian Society of Paediatric Neurology (SINP) Study Group on Childhood MS in the group of MS patients with the earliest onset of disease (i.e., <10 years of age).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15727227     DOI: 10.1007/s10072-004-0335-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Childhood multiple sclerosis and related disorders.

Authors:  Amna Al-Futaisi
Journal:  Oman Med J       Date:  2007-10

2.  Inflammatory Demyelinating Diseases of Childhood: Case Report and Literature Review.

Authors:  Esme Ekizoğlu; Pınar Tektürk Topaloğlu; Zuhal Yapici; Mefkûre Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

3.  Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.

Authors:  Rachel Aliotta; Jennifer L Cox; Katelyn Donohue; Bianca Weinstock-Guttman; E Ann Yeh; Paul Polak; Michael G Dwyer; Robert Zivadinov
Journal:  Hum Brain Mapp       Date:  2012-08-30       Impact factor: 5.038

4.  Extensive acute axonal damage in pediatric multiple sclerosis lesions.

Authors:  Sabine Pfeifenbring; Reem F Bunyan; Imke Metz; Christian Röver; Peter Huppke; Jutta Gärtner; Claudia F Lucchinetti; Wolfgang Brück
Journal:  Ann Neurol       Date:  2015-02-26       Impact factor: 10.422

Review 5.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

6.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

7.  Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.

Authors:  Katherine A McLaughlin; Tanuja Chitnis; Jia Newcombe; Bettina Franz; Julia Kennedy; Shannon McArdel; Jens Kuhle; Ludwig Kappos; Kevin Rostasy; Daniela Pohl; Donald Gagne; Jayne M Ness; Silvia Tenembaum; Kevin C O'Connor; Vissia Viglietta; Susan J Wong; Norma P Tavakoli; Jerome de Seze; Zhannat Idrissova; Samia J Khoury; Amit Bar-Or; David A Hafler; Brenda Banwell; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-08-17       Impact factor: 5.422

Review 8.  Pediatric multiple sclerosis.

Authors:  Dorothée Chabas; Ari J Green; Emmanuelle Waubant
Journal:  NeuroRx       Date:  2006-04

9.  Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.

Authors:  Silvia Dell'Avvento; Maria Alessandra Sotgiu; Salvatorica Manca; Giovanni Sotgiu; Stefano Sotgiu
Journal:  Eur J Pediatr       Date:  2015-07-10       Impact factor: 3.183

Review 10.  Use of Disease-Modifying Therapies in Pediatric MS.

Authors:  Marta Simone; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.